American Bio Medica (ABMC) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisChartSEC FilingsShort InterestBuy This Stock American Bio Medica Short Interest DataAmerican Bio Medica (ABMC) has a short interest of 100 shares, representing 0.00% of the float (the number of shares available for trading by the public). This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 21,583 shares to cover all short positions.Current Short Interest100 sharesPrevious Short Interest100 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$0.00Short Interest Ratio0.0 Days to CoverLast Record DateMarch 31, 2025Outstanding Shares48,098,000 sharesShort Percent of Float0.00%Today's Trading Volume0 sharesAverage Trading Volume21,583 sharesToday's Volume Vs. Average0% Short Selling American Bio Medica? Sign up to receive the latest short interest report for American Bio Medica and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartABMC Short Interest Over TimeABMC Days to Cover Over TimeABMC Percentage of Float Shorted Over Time American Bio Medica Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2025100 shares $0.00 No Change0.0%0 $0.00 3/15/2025100 shares $0.01 No Change0.0%1 $0.00 2/28/2025100 shares $0.00 No Change0.0%0 $0.00 2/15/2025100 shares $0.00 No Change0.0%0 $0.00 1/31/2025100 shares $0.00 No ChangeN/A0 $0.00 1/15/2025100 shares $0.00 No ChangeN/A0.3 $0.00 12/31/2024100 shares $0.00 No ChangeN/A0 $0.00 12/15/2024100 shares $0.00 No ChangeN/A0 $0.00 11/30/2024100 shares $0.00 No ChangeN/A0 $0.00 11/15/2024100 shares $0.00 No ChangeN/A0 $0.00 Get the Latest News and Ratings for ABMC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for American Bio Medica and its competitors with MarketBeat's FREE daily newsletter. 10/31/2024100 shares $0.00 No ChangeN/A0.2 $0.00 10/15/2024100 shares $0.00 No ChangeN/A0.3 $0.00 9/30/2024100 shares $0.00 No ChangeN/A0 $0.00 9/15/2024100 shares $0.00 No ChangeN/A0.1 $0.00 8/31/2024100 shares $0.00 No ChangeN/A0 $0.00 8/15/2024100 shares $0.00 No ChangeN/A0.2 $0.00 7/31/2024100 shares $0.00 No ChangeN/A0.5 $0.00 7/15/2024100 shares $0.01 -50.0%N/A0 $0.00 6/30/2024200 shares $0.00 No ChangeN/A0.1 $0.00 6/15/2024200 shares $0.00 No ChangeN/A0 $0.00 5/31/2024200 shares $0.00 No ChangeN/A0.1 $0.00 5/15/2024200 shares $0.06 No ChangeN/A0.2 $0.00 4/30/2024200 shares $0.40 No ChangeN/A0 $0.00 4/15/2024200 shares $0.06 No ChangeN/A0.2 $0.00 3/31/2024200 shares $0.06 No ChangeN/A0.1 $0.00 3/15/2024200 shares $0.06 No ChangeN/A0.1 $0.00 2/29/2024200 shares $0.00 No ChangeN/A0 $0.00 2/15/2024200 shares $0.00 No ChangeN/A0.1 $0.00 1/15/2024200 shares $0.00 No ChangeN/A0 $0.00 12/31/2023200 shares $0.00 No ChangeN/A0 $0.00 12/15/2023200 shares $0.10 -87.5%N/A0 $0.00 11/30/20231,600 shares $0.32 No ChangeN/A0 $0.00 11/15/20231,600 shares $0.00 No ChangeN/A0 $0.00 10/31/20231,600 shares $4.00 No ChangeN/A0.1 $0.00 10/15/20231,600 shares $6.40 No ChangeN/A0 $0.00 9/30/20231,600 shares $9.44 +33.3%N/A0.1 $0.01 9/15/20231,200 shares $7.80 -20.0%N/A0 $0.01 8/31/20231,500 shares $10.50 No ChangeN/A0 $0.01 6/30/2023100 shares $0.96 No ChangeN/A0 $0.01 5/15/2023100 shares $1.18 -99.0%N/A0 $0.01Silicon Valley Gold Rush (Ad)A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.Gates and Altman are betting big—see why 4/30/202310,300 shares $133.90 No ChangeN/A0.2 $0.01 11/30/20222,900 shares $36.83 No ChangeN/A0.1 $0.01 7/31/20225,200 shares $109.20 No ChangeN/A0.2 $0.02 5/15/202211,300 shares $226.00 No ChangeN/A0.1 $0.02 2/15/202214,100 shares $446.97 -42.5%N/A0.5 $0.03 1/31/202224,500 shares $796.25 -34.0%N/A1.1 $0.03 1/15/202237,100 shares $1,484.00 No ChangeN/A0.2 $0.04 11/30/202131,100 shares $1,290.65 +143.0%N/A0.1 $0.04 11/15/202112,800 shares $540.16 -95.3%N/A0.1 $0.04 10/29/2021271,500 shares $14,118.00 +16,868.8%N/A0.3 $0.05 10/15/20211,600 shares $67.52 -95.0%N/A0 $0.04 9/30/202131,700 shares $1,676.93 +387.7%N/A0.2 $0.05 9/15/20216,500 shares $258.70 -29.4%N/A0.1 $0.04 8/31/20219,200 shares $404.80 +29.6%N/A0 $0.04 8/13/20217,100 shares $347.90 No ChangeN/A0 $0.05 6/30/202115,500 shares $914.50 +7,650.0%N/A0 $0.06 6/15/2021200 shares $16.10 No ChangeN/A0 $0.08 5/28/2021200 shares $12.42 No ChangeN/A0 $0.06 5/14/2021200 shares $14.88 -98.7%N/A0 $0.07 4/30/202115,200 shares $1,275.28 +61.7%N/A0.1 $0.08 4/15/20219,400 shares $1,034.00 +9,300.0%N/A0 $0.11 3/31/2021100 shares $12.00 -99.7%N/A0 $0.12 3/15/202129,100 shares $4,365.00 +5,720.0%N/A0.1 $0.15 2/26/2021500 shares $94.85 -98.6%N/A0 $0.19 2/12/202136,600 shares $8,784.00 +42.4%N/A0.1 $0.24 1/29/202125,700 shares $6,168.00 No ChangeN/A0 $0.24 1/15/202115,100 shares $3,020.00 No ChangeN/A0 $0.20 12/31/202015,100 shares $1,959.98 No ChangeN/A0 $0.13 12/15/202015,100 shares $2,023.40 No ChangeN/A0 $0.13 11/15/20201,700 shares $390.83 -66.0%N/A0 $0.23 10/30/20205,000 shares $1,299.50 No ChangeN/A0 $0.26 9/30/20208,300 shares $1,577.00 -30.3%N/A0 $0.19 9/15/202011,900 shares $3,216.57 +11,800.0%N/A0 $0.27 8/31/2020100 shares $28.50 -98.3%N/A0 $0.29 8/14/20205,700 shares $1,667.25 -68.0%N/A0 $0.29 7/31/202017,800 shares $12,994.00 -80.3%N/A0 $0.73 7/15/202090,200 shares $106,436.00 -8.0%N/A0.1 $1.18 6/30/202098,000 shares $82,810.00 No ChangeN/A0.1 $0.85 5/29/20202,300 shares $592.25 -96.6%N/A0 $0.26 5/15/202068,500 shares $12,330.00 +705.9%N/A0.2 $0.18 4/30/20208,500 shares $1,338.75 -59.3%N/A0 $0.16 ABMC Short Interest - Frequently Asked Questions What is American Bio Medica's current short interest? Short interest is the volume of American Bio Medica shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 100 shares of ABMC short. 0.00% of American Bio Medica's shares are currently sold short. Learn More on American Bio Medica's current short interest. What is a good short interest percentage for American Bio Medica? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.00% of American Bio Medica's floating shares are currently sold short. How does American Bio Medica's short interest compare to its competitors? 0.00% of American Bio Medica's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to American Bio Medica: NovAccess Global Inc. (0.00%), Sienna Biopharmaceuticals, Inc. (0.00%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks. What does it mean to sell short American Bio Medica stock? Short selling ABMC is an investing strategy that aims to generate trading profit from American Bio Medica as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against American Bio Medica? A short squeeze for American Bio Medica occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ABMC, which in turn drives the price of the stock up even further. How often is American Bio Medica's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ABMC, twice per month. The most recent reporting period available is March, 31 2025. More Short Interest Resources from MarketBeat Related Companies NovAccess Global Short Interest Sienna Biopharmaceuticals Short Interest 4Front Ventures Short Interest Agentix Short Interest Algernon Pharmaceuticals Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:ABMC) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersDonald Trump is about to free crypto from its chains …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding American Bio Medica Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share American Bio Medica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
